Stage III Lymphoepithelioma of the Nasopharynx

8 clinical trials · Condition

Record	Firm	Date
Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy (NCT02123511)	Mayo Clinic	2014-04-01
Transoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer (NCT01254734)	City of Hope Medical Center	2011-04-01
L-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For Head and Neck Cancer (NCT01155609)	University of Washington	2010-09-01
Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC) (NCT00896181)	Stanford University	2008-12-10
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer (NCT00492089)	National Cancer Institute (NCI)	2007-06-01
Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer (NCT00101348)	National Cancer Institute (NCI)	2005-01-01
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00089362)	National Cancer Institute (NCI)	2004-07-01
Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer (NCT00023959)	National Cancer Institute (NCI)	2001-07-01

Every clearance here is in the API, with alerts when new ones post.